Hospital
Kershaw Hospital LLC
Kershaw Hospital LLC was paid $7.93M by Medicaid between Jan 2018 and Aug 2021, across 153 billing codes. Its largest line is 36415, Collection of venous blood by venipuncture — 20% of everything it billed.
33Billing provider infoKERSHAW HOSPITAL LLC
CAMDEN, SC 29020
CAMDEN, SC 29020
33aNPI1245220300assigned 10/28/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.93M
24GClaims227,105
24DCodes billed153
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#41 of 115
Median peer was paid$2.47M
This provider vs. median3.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TEAGUE, KATHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 73,860 | $2.48M | |
| 2019 | 68,155 | $2.29M | |
| 2020 | 52,179 | $1.80M | |
| 2021 | 32,911 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 20% | 12,550 | 9,069 | $1.55M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 15,317 | 13,827 | $799K |
| 80053 | Comprehensive metabolic panel | 9.4% | 10,523 | 8,304 | $742K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 8.5% | 2,423 | 2,138 | $671K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.2% | 10,785 | 5,189 | $416K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.0% | 2,022 | 1,851 | $315K |
| 87081 | 3.9% | 3,305 | 3,134 | $311K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.7% | 5,248 | 4,118 | $293K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 1,525 | 1,424 | $225K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.6% | 6,335 | 5,667 | $208K |
| 81001 | 2.6% | 9,100 | 7,446 | $204K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 4,658 | 1,133 | $163K |
141 more codes
| 81003 | 2.0% | 4,362 | $156K | |
| 87077 | 1.7% | 2,315 | $131K | |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 3,444 | $131K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.6% | 355 | $123K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 2,038 | $100K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 3,077 | $84K |
| 73610 | <1% | 850 | $78K | |
| 99284 | Emergency room visit (serious) | <1% | 8,436 | $76K |
| 73630 | <1% | 1,018 | $69K | |
| 73130 | <1% | 621 | $67K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 766 | $66K |
| 73562 | <1% | 965 | $64K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 607 | $58K |
| 81025 | <1% | 5,501 | $52K | |
| 73110 | <1% | 462 | $49K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,038 | $48K |
| 73030 | <1% | 638 | $46K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,222 | $42K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 526 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,232 | $38K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,455 | $38K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 602 | $34K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 786 | $34K |
| 72100 | <1% | 660 | $31K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 723 | $30K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,567 | $26K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,427 | $23K |
| 74018 | <1% | 548 | $22K | |
| 99285 | Emergency room visit (most serious) | <1% | 3,266 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,814 | $17K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 82 | $15K |
| 87210 | <1% | 381 | $14K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 199 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,574 | $13K |
| 87070 | <1% | 187 | $13K | |
| 93971 | <1% | 55 | $13K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,491 | $13K |
| 87807 | <1% | 544 | $10K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 957 | $8K |
| 59025 | Fetal non-stress test | <1% | 51 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 871 | $7K |
| 73502 | <1% | 114 | $7K | |
| 85027 | <1% | 2,089 | $7K | |
| 84702 | <1% | 1,090 | $6K | |
| 36600 | <1% | 150 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 637 | $6K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 120 | $6K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 12 | $5K |
| 88304 | <1% | 173 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 377 | $4K |
| 97161 | <1% | 157 | $4K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 104 | $4K |
| 74022 | <1% | 347 | $4K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 222 | $4K |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 65 | $3K |
| 73080 | <1% | 40 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,235 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 59 | $3K |
| 72040 | <1% | 39 | $3K | |
| 73090 | <1% | 30 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,436 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 140 | $3K |
| G0378 | Hospital observation service, per hour | <1% | 830 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 43 | $2K |
| 73140 | <1% | 13 | $2K | |
| 73590 | <1% | 39 | $2K | |
| 97162 | <1% | 69 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 499 | $2K |
| 76775 | <1% | 26 | $1K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 160 | $1K |
| 71100 | <1% | 15 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 92 | $1K |
| 76642 | <1% | 24 | $964.05 | |
| 85610 | <1% | 1,498 | $913.05 | |
| J3490 | Unclassified drugs | <1% | 1,585 | $877.63 |
| 83735 | <1% | 2,282 | $854.58 | |
| 86900 | <1% | 512 | $844.21 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,213 | $780.12 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,512 | $699.70 |
| 74019 | <1% | 29 | $662.78 | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,267 | $628.59 |
| 80143 | <1% | 76 | $513.70 | |
| 94664 | <1% | 54 | $507.29 | |
| 94644 | <1% | 45 | $486.44 | |
| 86850 | <1% | 130 | $328.22 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,076 | $278.82 |
| 80061 | Lipid panel | <1% | 403 | $272.69 |
| 93017 | <1% | 83 | $272.07 | |
| 85379 | <1% | 423 | $227.89 | |
| 82550 | <1% | 1,385 | $195.75 | |
| 80076 | <1% | 332 | $169.94 | |
| 83880 | <1% | 790 | $147.37 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,473 | $144.32 |
| 84484 | <1% | 3,370 | $142.57 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,071 | $126.95 |
| 84439 | <1% | 192 | $97.38 | |
| 82570 | <1% | 28 | $92.60 | |
| 83605 | <1% | 944 | $72.83 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 573 | $71.21 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,178 | $67.63 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 50 | $42.30 |
| 82247 | <1% | 15 | $13.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 388 | $12.51 |
| 82077 | <1% | 220 | $7.77 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,934 | $5.56 |
| 83690 | <1% | 1,983 | $4.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,382 | $1.24 |
| 87186 | 0% | 1,814 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 301 | $0.00 |
| 84145 | 0% | 504 | $0.00 | |
| 80179 | 0% | 77 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 715 | $0.00 |
| 84100 | 0% | 16 | $0.00 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 42 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 30 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 28 | $0.00 |
| 90715 | 0% | 39 | $0.00 | |
| 84156 | 0% | 13 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 28 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 297 | $0.00 |
| 82150 | 0% | 74 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 4,379 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 1,045 | $0.00 |
| 86901 | 0% | 512 | $0.00 | |
| 87040 | 0% | 854 | $0.00 | |
| 82803 | 0% | 259 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 56 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 397 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 2,311 | $0.00 |
| 96376 | 0% | 636 | $0.00 | |
| 82553 | 0% | 938 | $0.00 | |
| 85730 | 0% | 28 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 69 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 44 | $0.00 |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 0% | 13 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 41 | $0.00 |
| 85652 | 0% | 44 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 14 | $0.00 |
| 87205 | 0% | 13 | $0.00 | |
| 00160 | 0% | 16 | $0.00 | |
| 82728 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTEAGUE, KATHY (ASSISTANT VICE PRESIDENT, SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| Rchp-Wilmington, LLC | Wilmington, OH | $13.53M |
| Providence Hospital, LLC | Columbia, SC | $12.68M |
| Vaughan Regional Medical Center LLC | Selma, AL | $8.15M |
| Bolivar Physician Practices LLC | Cleveland, MS | $3.05M |
| Wilmington Physicians Group LLC | Wilmington, OH | $3.04M |
| Phc-Morgan City LP | Morgan City, LA | $2.37M |
| Community Hospital of Andalusia LLC | Andalusia, AL | $2.27M |
| Vaughan Regional Medical Center LLC | Marion, AL | $2.15M |
| PRHC Ennis LP | Ennis, TX | $1.81M |
| Andalusia Physician Practices LLC | Andalusia, AL | $847K |
| Meadowview Physician Practice LLC | Maysville, KY | $783K |
| Logan Physician Practice LLC | Auburn, KY | $458K |
| Logan Physician Practice LLC | Russellville, KY | $317K |
| Kentucky Mso LLC | Georgetown, KY | $248K |
| Rchp-Wilmington, LLC | Wilmington, OH | $165K |
| Meadowview Physician Practice LLC | Maysville, KY | $140K |
| Amg-Southern Tennessee LLC | Monteagle, TN | $136K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $135K |
| Lake Cumberland Physician Practices LLC | Somerset, KY | $57K |
| Kershaw Hospital LLC | Lugoff, SC | $49K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.